Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics

被引:5
|
作者
Ahmad, Iffat Zareen [1 ]
Kuddus, Mohammed [2 ]
Tabassum, Heena [1 ]
Ahmad, Asad [1 ]
Mabood, Abdul [1 ]
机构
[1] Integral Univ, Dept Bioengn & Biosci, Lucknow 226026, Uttar Pradesh, India
[2] Univ Hail, Coll Med, Dept Biochem, Hail, Saudi Arabia
关键词
Nanomaterial; characterization; diagnosis; therapeutic; drug delivery; theranostic; cancer; TARGETED DRUG-DELIVERY; MONODISPERSE MAGNETITE NANOPARTICLES; MESOPOROUS SILICA NANOPARTICLES; SOLID LIPID NANOPARTICLES; IRON-OXIDE NANOPARTICLES; IN-VIVO; QUANTUM DOTS; PHOTOTHERMAL THERAPY; GRAPHENE OXIDE; FE3O4; NANOPARTICLES;
D O I
10.2174/1389200218666171002122039
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Nanostructured material is a solid substance with at least one face is in the range of 1-100 nm. Manipulations in the characteristics and effects of nanostructures can invent new procedures and technologies, as the physical and chemical properties of nanomaterials are noticeably dissimilar from those of a single atom or its bulk phase. This difference in the properties is due to different spatial arrangements and shapes, changes in phase, energetics, electronic structure, chemical reactivity, and catalytic properties of huge, finite systems, and their assemblages. Theranostic involves the study of compounds which associates the modalities of curative and investigative purposes. Objective: The aim of this review was to highlight the possible uses of nanoparticles as therapeutic and diagnostic agents. As is evident by the latest applications of nanoparticles in the development of sensitive biosensors as well as in MRI and drug delivery systems. The most important theranostic application of nanoparticles involves the treatment of cancer. In most of the cases, the late diagnosis of the disease is responsible for increasing the mortality rate. Moreover, the toxic effect of the chemotherapeutic drugs on the normal cells of the body seems to be another major drawback of the treatment. Therefore, theranostics appears to be very helpful and realistic area in the diagnosis and targeted drug delivery of this particular disease. Methods: We systematically searched for research literature using well-framed review questions and presented data in both the text as well as tabular forms for readers' convenience. The present review collected the data from the published reviews as well as original research papers. The manuscripts considered in this article were taken from the databases and search engines comprising NCBI, PubMed, Google scholar, directory of open access journals, ScienceDirect and local library searches. The properties of the selected articles were analyzed, and a rational quantitative and qualitative content were used for the outcome and inference of the study applying a conceptual foundation. Results: Two hundred seventeen papers were included in the review. Most of the papers were from developed countries (163) and the rest from developing countries (54). Seventy four articles dealt with both the diagnostic as well as therapeutic study of nanomaterials, fifty seven manuscripts included only therapeutic approach and twenty seven papers included only diagnostic approach. The rest of the articles included the data on the synthesis and characterization of surface modified nanomaterials which could be applied in this area. Forty five papers dealt with both in vitro and in vitro studies, sixteen manuscripts involved studies on clinical trials, fifty nine articles gave data on the basis of in vitro experiments and twenty seven articles on the basis of in vivo studies only while 2 papers included in situ data. In the manuscripts considered for the review, the data on both the solid tumors as well as cancers were taken. Almost all types of cancers are being studied using nanomaterials but the most studied cancer for therapeutic and diagnostic approach on the basis of literature is breast cancer. Conclusion: By the help of surface modification of the nanomaterials specific targeting properties towards specific molecules and receptors in various types of cells could be achieved. It has been suggested that the delivered drugs require low amount to achieve the synergy between both the drugs delivered to cancer cells and tissues. Moreover, the toxic effect of the chemotherapeutic drugs on the normal cells of the body is another major drawback of the treatment. Upon further improvement and optimization of these nanoparticle-based strategies, it will ultimately lead to the prediction of patient's response towards a specific molecular therapy and it will be helpful to observe their responses to personalized therapy. Therefore, theranostics appears to be very helpful and realistic area in the diagnosis and targeted drug delivery of this particular disease.
引用
收藏
页码:983 / 999
页数:17
相关论文
共 50 条
  • [41] Recent Advancements of Magnetic Nanomaterials in Cancer Therapy
    Mukherjee, Sudip
    Liang, Lily
    Veiseh, Omid
    PHARMACEUTICS, 2020, 12 (02)
  • [42] Nanomaterials for the theranostics of obesity
    Li, Juanjuan
    Cha, Ruitao
    Luo, Huize
    Hao, Wenshuai
    Zhang, Yan
    Jiang, Xingyu
    BIOMATERIALS, 2019, 223
  • [43] Recent advancements in the surface modification and functionalization of magnetic nanomaterials
    Manoj, G. Murali
    Shalini, M.
    Thenmozhi, K.
    Ponnusamy, Vinoth Kumar
    Hari, Shankar
    APPLIED SURFACE SCIENCE ADVANCES, 2024, 21
  • [44] Recent advances in the metal/organic hybrid nanomaterials for cancer theranostics
    Ye, Zhaoyi
    Bao, Ying
    Chen, Zefeng
    Ye, Huiling
    Feng, Zhenzhen
    Li, Yushan
    Zeng, Yaoxun
    Pan, Zhenxing
    Ouyang, Defang
    Zhang, Kun
    Liu, Xujie
    He, Yan
    COORDINATION CHEMISTRY REVIEWS, 2024, 504
  • [45] Smart nanomaterials as the foundation of a combination approach for efficient cancer theranostics
    Panda, S.
    Hajra, S.
    Kaushik, A.
    Rubahn, H. G.
    Mishra, Y. K.
    Kim, H. J.
    MATERIALS TODAY CHEMISTRY, 2022, 26
  • [46] Emerging 2D Nanomaterials for Multimodel Theranostics of Cancer
    Zhu, Wei
    Li, Helin
    Luo, Peng
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2021, 9
  • [47] Towards Nanomaterials for Cancer Theranostics: A System of DNA-Modified Magnetic Nanoparticles for Detection and Suppression of RNA Marker in Cancer Cells
    Bakshi, Saira
    Zakharchenko, Andrey
    Minko, Sergiy
    Kolpashchikov, Dmitry M.
    Katz, Evgeny
    MAGNETOCHEMISTRY, 2019, 5 (02)
  • [48] Smart nanomaterials as the foundation of a combination approach for efficient cancer theranostics
    Panda, S.
    Hajra, S.
    Kaushik, A.
    Rubahn, H.G.
    Mishra, Y.K.
    Kim, H.J.
    Materials Today Chemistry, 2022, 26
  • [49] Recent progress in two-dimensional nanomaterials for cancer theranostics
    Liu, Jinxing
    Zhao, Chong
    Chen, Wei R.
    Zhou, Benqing
    COORDINATION CHEMISTRY REVIEWS, 2022, 469
  • [50] Making nanomaterials work in 3D cancer theranostics
    Bradley, David
    MATERIALS TODAY, 2020, 36 : 4 - 4